Ozempic
-
Novo Nordisk will slash Ozempic price for some, ‘aligning’ with genericsOzempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage dispensed, in some cases more than $450.HealthMay 26
-
Generic semaglutide to hit Canadian pharmacies this week at lower costHealth Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic and Wegovy — about three weeks ago.HealthMay 20
-
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s howPatients can receive the treatments at home for 'no additional cost' and will have the option of chatting with a pharmacist over the phone, Novo Nordisk said.CanadaMay 13
![]()
-
Health Canada approves country’s 1st generic version of OzempicThe injectable semaglutide medication is manufactured by Dr. Reddy's Laboratories in India and is approved for the once-weekly treatment of Type 2 diabetes in adults.HealthApr 28
![]()
-
Could GLP-1 drugs help your mental health? New study finds a linkSemaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.HealthMar 20
![]()
-
Many regain weight after stopping GLP-1 drugs, data shows. Here’s whyPeople on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review of 63 trials covering over 9,000 individuals showed.HealthJan 8
![]()
-
Generic Ozempic can be made in Canada as of next week. Will it be cheaper?As of Dec. 29, Health Canada had received nine submissions seeking approval to make semaglutide, the active ingredient in Ozempic and Wegovy.HealthJan 2
![]()
-
Trump says prices for Ozempic, other weight-loss drugs to drop in U.S.Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.U.S. NewsNov 6, 2025
![]()
-
Ozempic, Wegovy makers Novo Nordisk announce 9K layoffs in restructuringOzempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in an attempt to fend off competition.WorldSep 10, 2025
![]()
-
Ozempic approved in Canada to reduce kidney decline in people with diabetesThe patients taking the drug were also less likely to die from cardiovascular disease — another condition that affects many patients with diabetes.HealthAug 19, 2025
![]()
